Bulletin
Investor Alert

Adagio Therapeutics Inc.

NAS: ADGI

GO
/marketstate/country/us

After Hours

/zigman2/quotes/228559245/composite

$

1.24

Change

+0.04 +3.33%

Volume

Volume 2,011

Mar 31, 2023, 7:22 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/228559245/composite

Previous close

$ 1.19

$ 1.20

Change

+0.02 +1.27%

Day low

Day high

$1.14

$1.24

Open
Open: 1.18

52 week low

52 week high

$1.03

$4.90

Open

Market cap

$129.39M

Average volume

238,033

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-2.23

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/adgi

MarketWatch News on ADGI

  1. Biotech Stocks Are Still Falling. The Near-Term Outlook Is Grim.

    10:21 a.m. May 2, 2022

    - Barron's Online

  2. Adagio Stock Spikes on New Data, but Its Omicron Problems Remain

    9:33 a.m. March 30, 2022

    - Barron's Online

  3. Adagio Therapeutics downgraded to underweight at Morgan Stanley

    11:45 a.m. Jan. 6, 2022

    - Tomi Kilgore

  4. Adagio Therapeutics downgraded to hold from buy at Stifel, price target slashed to $9 from $50

    10:25 a.m. Dec. 15, 2021

    - Tonya Garcia

  5. Adagio Therapeutics upgraded to overweight at Morgan Stanley

    10:30 a.m. Nov. 29, 2021

    - Tomi Kilgore

  6. Adagio Therapeutics started at buy with $57 stock price target at Stifel Nicolaus

    7:30 a.m. Aug. 31, 2021

    - Tomi Kilgore

  7. The IPO Market Is on Break. Adagio Is Friday's Only Deal.

    4:32 p.m. Aug. 6, 2021

    - Barron's Online

  8. Adagio Therapeutics sets IPO terms, to be valued at up to $1.8 bln

    6:38 a.m. Aug. 2, 2021

    - Tomi Kilgore

/news/nonmarketwatch/company/us/adgi

Other News on ADGI

  1. 10-K: INVIVYD, INC.

    4:33 p.m. March 23, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  2. Invivyd, Inc. 2022 Q3 - Results - Earnings Call Presentation

    11:41 p.m. Nov. 10, 2022

    - Seeking Alpha

  3. 10-Q: INVIVYD, INC.

    6:10 p.m. Nov. 10, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  4. ASTI, CABA and PEGY among mid-day movers

    1:04 p.m. Oct. 20, 2022

    - Seeking Alpha

  5. Invivyd Names Fred Driscoll as Interim CFO, Cuts Some Positions

    4:52 p.m. Oct. 13, 2022

    - The Wall Street Journal Interactive Edition

  6. Invivyd appoints interim CFO, makes headcount changes

    4:16 p.m. Oct. 13, 2022

    - Seeking Alpha

  7. Invivyd (IVVD) Investor Presentation - Slideshow

    6:06 p.m. Sept. 16, 2022

    - Seeking Alpha

  8. 10-Q: ADAGIO THERAPEUTICS, INC.

    8:12 a.m. Aug. 15, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  9. Adagio names David Hering as permanent CEO and Director

    7:34 a.m. July 5, 2022

    - Seeking Alpha

  10. 10-Q: ADAGIO THERAPEUTICS, INC.

    8:04 a.m. May 13, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  11. Adagio's (ADGI) COVID-19 Antibody Meets Goals in Studies

    12:14 p.m. March 31, 2022

    - Zacks.com

  12. 10-K: ADAGIO THERAPEUTICS, INC.

    8:21 a.m. March 31, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  13. AKBA, TMC and ISIG among mid-day movers

    12:42 p.m. March 30, 2022

    - Seeking Alpha

  14. Why Adagio Therapeutics Stock Is Soaring Today

    10:50 a.m. March 30, 2022

    - Motley Fool

  15. ABVC, SNOA and TISI among pre market gainers

    8:29 a.m. March 30, 2022

    - Seeking Alpha

  16. These 2 Nasdaq Biotech Stocks Are Soaring Wednesday Morning

    8:24 a.m. March 30, 2022

    - Motley Fool

  17. Loading more headlines...
/news/pressrelease/company/us/adgi

Press Releases on ADGI

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.